Physician profile
Stephen Frederick Kappa
NPI 1356600969
$8,528.16
in general payments reported to CMS, 2019-2025
39 companies · $1,657 in 2025
The $1,657 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,241 · 2020: $477 · 2021: $751 · 2022: $830 · 2023: $1,285 · 2024: $1,287 · 2025: $1,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,229.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,337.34 | 2019-2020 | |
| Teleflex LLC | $861.45 | 2021-2025 | Urolift |
| Astellas Pharma US INC | $838.18 | 2019-2024 | Myrbetriq |
| Janssen Biotech, INC. | $547.60 | 2019-2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $528.95 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $463.83 | 2019-2025 | |
| Boston Scientific Corporation | $463.28 | 2023-2025 | Ams 700, General - Erectile Dysfunction, Lithovue |
| Sumitomo Pharma America, INC. | $444.50 | 2023-2025 | Orgovyx, Gemtesa |
| Olympus America INC. | $412.13 | 2023-2025 | Itind System |
| Urogen Pharma, INC. | $389.07 | 2020-2025 | Jelmyto |
| Axonics, INC. | $296.67 | 2020-2023 | Axonics |
| Abbvie INC. | $240.18 | 2019-2024 | |
| Srs Medical Systems, INC. | $223.92 | 2022-2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Dornier Medtech America, INC | $128.33 | 2023 | Dornier Medtech |
| Tolmar Pharmaceuticals, INC. | $124.38 | 2019-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $117.58 | 2024-2025 | Adstiladrin |
| Laborie Medical Technologies Corp. | $112.76 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Medtronic, INC. | $108.93 | 2022-2025 | Interstim, Altaviva |
| Calyxo, INC. | $100.42 | 2022-2025 | Cvac Aspiration System |
| Immunitybio, INC. | $99.20 | 2025 | |
| Accord Healthcare, INC. | $77.56 | 2023-2025 | |
| Procept Biorobotics Corporation | $73.62 | 2021-2024 | Aquabeam System |
| Pfizer INC. | $65.33 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $56.61 | 2022-2024 | Lynparza, Welireg, Keytruda |
| Medtronic USA, INC. | $54.97 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $46.14 | 2021-2025 | |
| Myovant Sciences INC. | $36.53 | 2022 | |
| Photocure INC | $30.07 | 2019 | |
| 180 Medical, INC. | $29.13 | 2019 | |
| Urovant Sciences INC | $28.79 | 2022 | |
| Allergan, INC. | $28.39 | 2021 | |
| Amgen INC. | $24.65 | 2019 | |
| Clinigen, INC. | $24.52 | 2019 | |
| Progenics Pharmaceuticals, INC. | $23.77 | 2023 | Pylarify |
| Coloplast Corp | $23.46 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $19.43 | 2024 | Aveed, Xiaflex |
| Coopersurgical, INC. | $16.50 | 2025 | Onetrac Lx |
| Astrazeneca Pharmaceuticals LP | $15.70 | 2025 | |
| Bard Peripheral Vascular, INC. | $14.29 | 2025 | Model 200 Theraseed Palladium-103 In Readylink |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kappa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.